WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.

Neuro-oncology advances(2023)

引用 1|浏览13
暂无评分
摘要
WSD-0922 is a highly potent inhibitor of EGFR in GBM, and warrants further evaluation in clinical studies.
更多
查看译文
关键词
blood-brain barrier, EGFR, erlotinib, glioblastoma, WSD-0922
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要